| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8244199 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 7 Pages |
Abstract
Conclusions: Intensity-modulated stereotactic radiotherapy can be safely delivered to improve the dose distributions in select skull-base meningiomas with an appreciable concomitant dose reduction to involved critical structures. Longer follow-up with a larger patient group is necessary to demonstrate sustained tumor control and low morbidity with IMSRT for small inoperable, recurrent, or subtotally resected meningiomas.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Kamil M. Ph.D., Ashwatha M.D., Jenghwa Ph.D., Philip H. M.D., Howard I. Ph.D.,